✦ LIBER ✦

9123 POSTER Final Results of a Phase II Study of Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Non-small Cell Lung Cancer – Gefitinib for Elderly Patients With Lung Adenocarcinoma

✍ Scribed by Asami, K.; Koizumi, T.; Hirai, K.; Ameshima, S.; Tsukadaira, A.; Morozumi, N.; Morikawa, A.; Atagi, S.; Kawahara, M.; Komatsu, Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gefitinib as First-line Treatment in Eld

✍ Kazuhiro Asami; Tomonobu Koizumi; Kazuya Hirai; Shingo Ameshima; Akihiro Tsukada 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 308 KB

A phase II trial of gefitinib as first-l

✍ Asahina, H; Yamazaki, K; Kinoshita, I; Sukoh, N; Harada, M; Yokouchi, H; Ishida, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 139 KB

Gefitinib as first-line treatment for pa

✍ Gridelli, C.; De Marinis, F.; Di Maio, M.; Cortinovis, D.; Cappuzzo, F.; Mok, T. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 216 KB

Prospective Phase II Study of Gefitinib

✍ Inoue, A. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 262 KB

Clinical outcomes in elderly patients ad

✍ Kazunari Tateishi, Takashi Ichiyama, Kazuya Hirai, Toshihiko Agatsuma, Shigeru K 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 230 KB

First-Line Single Agent Treatment With G

✍ Niho, S. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 124 KB